Cargando…

Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale

Colchicine is commonly used as part of the treatment of acute and recurrent pericarditis. Neuromyopathy is a well-known, but probably underreported, side effect of colchicine. Here we present a unique case of a 56-year-old woman with recurrent episodes of colchicine-induced neuromyopathy over many y...

Descripción completa

Detalles Bibliográficos
Autores principales: Perzon, Ofer, Kenig, Ariel, Fellig, Yakov, Mevorach, Dror
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663985/
https://www.ncbi.nlm.nih.gov/pubmed/36388708
http://dx.doi.org/10.1016/j.jaccas.2022.08.027
_version_ 1784831002973044736
author Perzon, Ofer
Kenig, Ariel
Fellig, Yakov
Mevorach, Dror
author_facet Perzon, Ofer
Kenig, Ariel
Fellig, Yakov
Mevorach, Dror
author_sort Perzon, Ofer
collection PubMed
description Colchicine is commonly used as part of the treatment of acute and recurrent pericarditis. Neuromyopathy is a well-known, but probably underreported, side effect of colchicine. Here we present a unique case of a 56-year-old woman with recurrent episodes of colchicine-induced neuromyopathy over many years. (Level of Difficulty: Beginner.)
format Online
Article
Text
id pubmed-9663985
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96639852022-11-15 Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale Perzon, Ofer Kenig, Ariel Fellig, Yakov Mevorach, Dror JACC Case Rep Case Report Colchicine is commonly used as part of the treatment of acute and recurrent pericarditis. Neuromyopathy is a well-known, but probably underreported, side effect of colchicine. Here we present a unique case of a 56-year-old woman with recurrent episodes of colchicine-induced neuromyopathy over many years. (Level of Difficulty: Beginner.) Elsevier 2022-11-02 /pmc/articles/PMC9663985/ /pubmed/36388708 http://dx.doi.org/10.1016/j.jaccas.2022.08.027 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Perzon, Ofer
Kenig, Ariel
Fellig, Yakov
Mevorach, Dror
Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale
title Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale
title_full Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale
title_fullStr Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale
title_full_unstemmed Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale
title_short Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale
title_sort use of colchicine for pericardial inflammation: risks and toxicities—a cautionary tale
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663985/
https://www.ncbi.nlm.nih.gov/pubmed/36388708
http://dx.doi.org/10.1016/j.jaccas.2022.08.027
work_keys_str_mv AT perzonofer useofcolchicineforpericardialinflammationrisksandtoxicitiesacautionarytale
AT kenigariel useofcolchicineforpericardialinflammationrisksandtoxicitiesacautionarytale
AT felligyakov useofcolchicineforpericardialinflammationrisksandtoxicitiesacautionarytale
AT mevorachdror useofcolchicineforpericardialinflammationrisksandtoxicitiesacautionarytale